News

September 16, 2016

Lack of Vaccinations Increased Risk of HPV Infections in Japan

News

Japanese women who became adolescents between 1993 and 2008, a period in which vaccination against cervical cancer was temporarily suspended, are at higher risk of having HPV16/18 infection, which is known ... Read more

September 14, 2016September 14, 2016

Europe Seen to Have Least Confidence in Vaccine Safety in Global Survey

News

Public confidence in vaccines diverges between countries and world regions, with Europe being the region most distrustful of vaccine safety, according to the results of the largest global survey of confidence in vaccines published in ... Read more

September 12, 2016

Test to Detect HPV Linked to Cervical Cancers Up for FDA Approval

News

Becton, Dickinson and Company (BD) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for its Onclarity HPV Assay, a test for human papillomavirus (HPV). There ... Read more

September 7, 2016September 7, 2016

HIV Infection Considerably Hurts Chances of Surviving Cervical Cancer, Study Finds

News

Cervical cancer patients who are also infected with HIV are at a significantly higher risk of dying than those who do not have the virus, according to a study of cervical cancer patients in ... Read more

August 11, 2016August 11, 2016

Routine Test Helps Prevent Cervical Cancer in Elderly Women, According to Study

News

A new study confirms that routine Pap smears, a screening test to detect abnormal cells that can become cervical cancer) reduces the risk of developing the disease in women ages 65 ... Read more

August 2, 2016August 2, 2016

4 Additional LuViva Cervical Scan Systems Shipped to Bangladesh

News

Guided Therapeutics recently shipped four additional LuViva Advanced Cervical Scan systems to Bangladesh for the country’s cervical cancer screening program. Bangladesh will now receive a total of 12 LuVivas and more ... Read more

July 13, 2016July 13, 2016

Phase 3 Study of Drug Candidate for Cervical Cancer Granted FDA Special Protocol Assessment

News

The U.S. Food and Drug Administration (FDA) has granted clinical stage biotechnology company Advaxis special approval for a Phase 3 clinical trial to evaluate the safety and effectiveness of the company’s lead ... Read more

June 23, 2016June 23, 2016

Kite Pharma Expands Development of Therapies Targeting HPV-Associated Cancers

News

Kite Pharma, a clinical-stage biopharma engaged in the development of novel cancer immunotherapy products, and the Experimental Transplantation and Immunology Branch (ETIB) of the National Cancer Institute signed a Cooperative ... Read more

May 5, 2016May 5, 2016

HPV Vaccines Effective But Ethnic Disparities in Access Still a Problem for US, Study Reports

News

Access to first- and second-generation human papillomavirus (HPV) vaccines that are expected to lower the risk for HPV-associated cancers in all racial/ethnic groups is the main finding of the recent study, “Racial and ... Read more

April 21, 2016April 21, 2016

HPV Vaccine Seen to Protect Teens with Kidney Disease from Cervical Cancer, But Not Those Who Needed a Transplant

News

Human papillomavirus (HPV) vaccination produces a robust and sustained immune response in girls and young women with chronic kidney disease (CKD) and those on dialysis, but a suboptimal response in those ... Read more